Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the alpha-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the alpha-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study
复制标题
使用甲胎蛋白启动子增强子和 pgk 启动子开发基于抑制蛋白磷酸酶 2A 的肝细胞癌基因治疗策略：体外和体内研究
作者：
Xu, Ze-Kuan;Zhu, Yi;Gong, FR;Tao, Min
